HLB Co., Ltd.
028300
Kedudukan dalam Saham
#4132
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Harga Saham
$29.60
Modal Pasaran
$3.93B
Perubahan (1 hari)
0.12%
Perubahan (1 tahun)
2.06%
Negara
KR
Perdagangan HLB Co., Ltd. (028300)
Kategori
Healthcare
EPS untuk HLB Co., Ltd. (028300)
EPS setakat June 2026 TTM: $-1.12
Menurut laporan kewangan terkini dan harga saham HLB Co., Ltd., EPS semasa syarikat (TTM) adalah $-1.12. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-1.20 peningkatan berbanding EPS tahun 2022 iaitu $-0.55.
Sejarah EPS untuk HLB Co., Ltd. dari 2012 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-1.12 | 132.67% |
| 2024 | $-0.48 | -60.27% |
| 2023 | $-1.20 | 119.01% |
| 2022 | $-0.55 | -19.90% |
| 2021 | $-0.69 | 15.14% |
| 2020 | $-0.60 | 57.18% |
| 2019 | $-0.38 | -259.25% |
| 2018 | $0.24 | -240.42% |
| 2017 | $-0.17 | 40.25% |
| 2016 | $-0.12 | -194.53% |
| 2015 | $0.13 | -689.86% |
| 2014 | $-0.02 | -80.40% |
| 2013 | $-0.11 | 8.00% |
| 2012 | $-0.10 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $17.32 | -1,650.86% |
US
|
|
| $-7.98 | 614.54% |
US
|
|
| $-5.29 | 373.67% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,583.88% |
NL
|
